Literature DB >> 33718293

Case Report: Two Infant Cases of Langerhans Cell Histiocytosis Involving the Digestive Tract.

Huan Wang1, Yuesheng Wang1, Ruifeng Wang1, Xiaoqin Li1.   

Abstract

Langerhans cell histiocytosis (LCH) is a rare disease with uncertain etiology. Langerhans cell histiocytosis with involvement of the gastrointestinal tract is rare and is typically identified in pediatric patients with systemic disease. The present study reports two infantile cases of LCH who initially presented with diarrhea, hematochezia, and rash and were histologically missed on the original examination of the colonic biopsy sections. The diagnosis of LCH was later verified through immunohistochemistry. By combining our experience and previous reports, the multiple hemorrhagic spots of the colorectal mucosa and narrowness and erosion of the distal duodenum might be suggestive manifestations of gastrointestinal involvement in LCH on endoscopic examination. This might be helpful for the early recognition of the disease.
Copyright © 2021 Wang, Wang, Wang and Li.

Entities:  

Keywords:  BRAF mutation (V600E); endoscopic manifestation; gastrointestinal tract; infant; langerhans cell histiocytosis

Year:  2021        PMID: 33718293      PMCID: PMC7943473          DOI: 10.3389/fped.2021.545771

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  13 in total

Review 1.  Langerhans cell histiocytosis with digestive tract involvement.

Authors:  Satya P Yadav; Gaurav Kharya; Neelam Mohan; Anupam Sehgal; Sunil Bhat; Sandeep Jain; Gauri Kapoor; Anupam Sachdeva
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

Review 2.  Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review.

Authors:  Elizabeth Hait; Marilyn Liang; Barbara Degar; Jonathan Glickman; Victor L Fox
Journal:  Pediatrics       Date:  2006-10-09       Impact factor: 7.124

3.  [Gastrointestinal involvement in Langerhans cell histiocytosis].

Authors:  M Andión Catalán; D Ruano Domínguez; D Azorín Cuadrillero; T de Rojas de Pablos; L Madero López
Journal:  An Pediatr (Barc)       Date:  2015-05-29       Impact factor: 1.500

4.  How I treat Langerhans cell histiocytosis.

Authors:  Carl E Allen; Stephan Ladisch; Kenneth L McClain
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

5.  Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition.

Authors:  Olive S Eckstein; Johannes Visser; Carlos Rodriguez-Galindo; Carl E Allen
Journal:  Blood       Date:  2019-02-04       Impact factor: 22.113

Review 6.  Langerhans cell histiocytosis involving the gastrointestinal tract.

Authors:  Amir Behdad; Scott R Owens
Journal:  Arch Pathol Lab Med       Date:  2014-10       Impact factor: 5.534

7.  Adult-onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo Clinic.

Authors:  Joshua O Podjasek; Conor G Loftus; Thomas C Smyrk; Carilyn N Wieland
Journal:  Int J Dermatol       Date:  2013-04-28       Impact factor: 2.736

8.  Gastrointestinal tract langerhans cell histiocytosis: A clinicopathologic study of 12 patients.

Authors:  Aatur D Singhi; Elizabeth A Montgomery
Journal:  Am J Surg Pathol       Date:  2011-02       Impact factor: 6.394

9.  Langerhans Cell Histiocytosis of the Gastrointestinal Tract: Evidence for Risk Organ Status.

Authors:  Hoi Soo Yoon; Jae Hee Lee; Jennifer Michlitsch; Manuel Garcia-Carega; Michael Jeng
Journal:  J Pediatr       Date:  2019-07-03       Impact factor: 4.406

10.  Langerhans Cell Histiocytosis of the Gastrointestinal Tract - A Rare Entity.

Authors:  Jasmine Bhinder; Amit Mori; Leon Kurtz; Madhavi Reddy
Journal:  Cureus       Date:  2018-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.